Device type · DIS
Enzyme Immunoassay, Barbiturate
Last checked: Nov 21, 2026Source: openFDAMethods & limitations
Product code
DIS
Clinical Toxicology
Device class
Class II
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 21, 2026
How FDA classifies it
- Device type
- Enzyme Immunoassay, Barbiturate
- Product code
- DIS
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3150
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DIS
Latest FDA decisions
K161714 · Decided Oct 14, 2016 · 115 days after receipt
Device type: Enzyme Immunoassay, Barbiturate (DIS) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 21, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1799-2020 · Started Jun 12, 2019
Reason given: The firm has identified that cross-reactivity testing may not meet the claims indicated in the Barbiturates Reagent Chemistry Information Sheet (CIS). The presence of certain compounds in urine may result in false positive or false negative results.
Cause as FDA categorized it: Under Investigation by firm
6 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.